Axordia Overview

  • Founded
  • 2001
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Axordia General Information

Description

Operator of a human embryonic stem cell company. The company develops drugs using the properties of stem cells and their derivatives as part of the drug discovery process.

Contact Information

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • The Sheffield Bioincubator
  • 40 Leavygreave Road
  • Sheffield S3 7RD
  • England, United Kingdom
+44 0114 000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Axordia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 00.000 Completed Product Development
3. Early Stage VC 01-Jan-2006 00000 00.000 Completed Startup
2. Grant 01-Apr-2002 $362K Completed
1. Early Stage VC 12-Nov-2001 $362K $362K Completed Product Development
To view Axordia’s complete valuation and funding history, request access »

Axordia Executive Team (1)

Name Title Board Seat Contact Info
V Gerskowitch Chief Executive Officer
To view Axordia’s complete executive team members history, request access »

Axordia Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
FusionIP Venture Capital Minority 000 0000 000000 0
White Rose Technology Seedcorn Fund Venture Capital Minority 000 0000 000000 0
To view Axordia’s complete investors history, request access »